|
SLN Silence Therapeutics Plc 1479615 |
| Balance Sheet |
|
Current Assets
|
187,366,000 |
|
Assets
|
202,635,000 |
|
Current Liabilities
|
16,822,000 |
|
Liabilities
|
68,612,000 |
|
Equity
|
134,023,000 |
|
Shares Out
|
139,980,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-67,640,000 |
|
Investing Cash Flow
|
-21,966,000 |
| Market Analysis |
Market Cap
|
855,442,484 |
|
Price
|
3.84 |
|
BVPS
|
0.96 |
|
PB
|
3.89 |
|
EPS
|
-1.27 |
|
PS
|
0.13 |
|
FCF
|
-89,606,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-0.33 |
3/13 |
0.24 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLN documents filed with the SEC.
SLN Filings
Clear
